ANWPX
Price
$74.10
Change
+$0.67 (+0.91%)
Updated
Jul 31 closing price
Net Assets
170.23B
CNGCX
Price
$66.79
Change
+$0.78 (+1.18%)
Updated
Jul 31 closing price
Net Assets
51.8B
Interact to see
Advertisement

ANWPX vs CNGCX

ANWPX vs CNGCX Comparison Chart in %
View a ticker or compare two or three
VS
ANWPX vs. CNGCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANWPX is a Buy and CNGCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ANWPX has more cash in the bank: 170B vs. CNGCX (51.8B). ANWPX pays higher dividends than CNGCX: ANWPX (0.98) vs CNGCX (0.00). ANWPX was incepted earlier than CNGCX: ANWPX (53 years) vs CNGCX (24 years). CNGCX (1.52) is less costly to investors than ANWPX (0.71). CNGCX is a more actively managed with annual turnover of: 36.00 vs. ANWPX (23.00). ANWPX (250) and CNGCX (250) have matching initial minimum investment requirements. CNGCX annual gain was more profitable for investors over the last year : 18.55 vs. ANWPX (6.80). CNGCX return over 5 years is better than : 17.82 vs. ANWPX (12.63).
ANWPXCNGCXANWPX / CNGCX
Total Expense Ratio0.711.5247%
Annual Report Gross Expense Ratio0.711.5247%
Fund Existence53 years24 years-
Gain YTD4.94314.89833%
Front Load6%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets170B51.8B328%
Annual Yield % from dividends0.980.00-
Returns for 1 year6.8018.5537%
Returns for 3 years33.9247.8371%
Returns for 5 years12.6317.8271%
Returns for 10 years106.8199.91107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PAXLX11.280.14
+1.26%
Impax Large Cap Fund Individual Investor
AGVFX31.080.17
+0.55%
American Funds Global Insight A
ETNEX16.540.08
+0.49%
Eventide Exponential Technologies N
FSKGX20.150.09
+0.45%
Fidelity Growth Strategies K6
BMSDX17.15-0.04
-0.23%
MFS Blended Research Mid Cap Eq C